Ferring Pharmaceuticals Inc. is voluntarily recalling approximately 1,168,147 units of Menopur 75 IU (menotropins for injection) due to the diluent (0.9% Sodium Chloride) having pH levels that fall outside of required specifications. This recall affects both standard 5-vial cartons and professional sample kits distributed nationwide. Consumers should be aware that the salt water solution used to mix the medication may not meet quality standards, which could potentially impact the medication's effectiveness or safety. Because this is a prescription fertility treatment, patients should immediately contact their healthcare provider or pharmacist for guidance on their specific treatment plan.
The pH level of the sodium chloride solution used to dissolve the medication is outside the required safety range. Using a solution with an improper pH can lead to irritation at the injection site or may potentially alter the stability and effectiveness of the medication being administered.
Contact healthcare provider and return product for refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.